Di Federico A, Alden SL, Smithy JW, Ricciuti B, et al. Intrapatient variation in PD-L1 expression and tumor mutational burden and the impact on outcomes to immune checkpoint inhibitor therapy in patients with non-small cell lung cancer. Ann Oncol 2024 Jun 29:S0923-7534(24)00745-2. doi: 10.1016/j.annonc.2024.
PMID: 38950679